Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-20

FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bupropion Hydrochloride XL from Actavis Pharma, Inc., formalizing approval of an extended-release generic formulatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)